Qigong for Multiple Sclerosis: A Feasibility Study

CompletedNot a drug-phase studyMS (type not specified)NCT04585659

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Qigong

What it measured

Main measures

  • Feasibility Outcome 1: Number of participants recruited for the study

    8 months

    Feasibility
  • Feasibility Outcome 2: Number of participants retained in the study

    10 weeks

    Feasibility
  • Feasibility Outcome 3: Percent able to participate in qigong classes

    10 weeks

    Feasibility
  • Feasibility Outcome 4: Percent attendance in qigong classes

    10 weeks

    Feasibility

Other measures (11)

  • Clinical Measure 1: Walking speed assessed by the Timed-25-Foot-Walk Test

    Baseline and 10 weeks

    Disability progressionWalking and mobility
  • Clinical Measure 2: Mobility, balance and walking ability assessed by the Timed-Up-and-Go Test

    Baseline and 10 weeks

    Walking and mobilityPhysical function
  • Clinical Measure 3: Multidirectional mobility assessed by the Four-Square-Step-Test

    Baseline and 10 weeks

    Walking and mobility
  • Clinical Measure 4: Physical and psychological well-being assessed by the Multiple Sclerosis Impact Scale (MSIS-29)

    Baseline and 10 weeks

    Physical functionQuality of life (reported by participants)
  • Clinical Measure 5: Impact of multiple sclerosis on walking ability assessed by the Multiple Sclerosis Walking Scale (MSWS-12)

    Baseline and 10 weeks

    Walking and mobility
  • Clinical Measure 6: Fatigue assessed by the Modified Fatigue Impact Scale Short Version (MFIS-5)

    Baseline and 10 weeks

    Thinking and memoryFatigue
  • Clinical Measure 7: Health-related quality of life assessed by the Patient Reported Outcomes Measurement Information System global heath (mental and physical, v1.1)

    Baseline and 10 weeks

    Quality of life (reported by participants)
  • Clinical Measure 8: Health-related quality of life assessed by the Patient Reported Outcomes Measurement Information System physical function (v1.2)

    Baseline and 10 weeks

    Quality of life (reported by participants)
  • Clinical Measure 9: Health-related quality of life assessed by the Patient Reported Outcomes Measurement Information System fatigue (v1.0)

    Baseline and 10 weeks

    FatigueQuality of life (reported by participants)
  • Clinical Measure 10: Health-related quality of life assessed by the Patient Reported Outcomes Measurement Information System anxiety (v1.0)

    Baseline and 10 weeks

    Mood and sleepQuality of life (reported by participants)

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

* Living in the Portland Metropolitan Area * Self-reported diagnosis of multiple sclerosis (MS - any type) * Demonstrated ability to walk 50 feet without assistance * Stable on disease-modifying or balance medications three months prior to baseline

Exclusion criteria

* Pregnant or nursing * Participated in qigong, tai chi, or yoga (>1 month) within six months prior to baseline * Had an MS relapse within 30 days prior to baseline.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This feasibility study explores a community-based qigong intervention for people with multiple sclerosis (MS). The primary aim is to assess the feasibility of weekly community qigong classes for people with MS. The secondary aim is to explore the effects of qigong on balance, gait, mood, fatigue, and quality of life.

Papers

Loading reviews and guidelines…

History

    1. Started

      Feb 2017

    2. Main results due

      Mar 2018

    3. Finished

      Mar 2018

    Assembled by software from public sources.